Dr. Hammoudeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
268 Martin Luther King Jr Blvd
Newark, NJ 07102
Education & Training
- University of Jordan Faculty of MedicineClass of 1986
- New York Medical College at St Michael's Medical CenterResidency, Internal Medicine
- Seton Hall University-Hackensack Meridian School of MedicineFellowship, Interventional Cardiology
Certifications & Licensure
- NJ State Medical License 1991 - 2015
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Statin Eligibility Prior to Myocardial InfarCtion Start of enrollment: 2019 Apr 22
- Surviving a Decade or More After Coronary Revascularization in a Middle Eastern Population Start of enrollment: 2018 Jun 01
- The Jordan Atrial Fibrillation Study: Baseline Risk Scores and One Year Outcome Start of enrollment: 2019 May 25
Roles: Study Chair, Contact, Sponsor-Investigator
- Join now to see all
Publications & Presentations
PubMed
- 12 citationsCardiovascular risk factors in Middle Eastern patients undergoing percutaneous coronary intervention: Results from the first Jordanian percutaneous coronary interventi...Ayman J. Hammoudeh, Imad A. Alhaddad, Yousef Khader, Ramzi Tabbalat, Eyas Al-Mousa
Journal of the Saudi Heart Association. 2017-07-01 - 47 citationsEffect of ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients: END-AF Trial.Ramzi Tabbalat, Nidal Hamad, Imad A. Alhaddad, Ayman J. Hammoudeh, Bassam F. Akasheh
American Heart Journal. 2016-08-01 - 4 citationsAssessing myocardial viability: Correlation of myocardial wall motion abnormalities and pathologic Q waves with technetium 99m sestamibi single photon emission compute...Jacob I. Haft, Ayman J. Hammoudeh, Patrick J. Conte
American Heart Journal. 1995-11-01
Press Mentions
- Cardiovascular Risk Categories and Attaining LDL-C Targets in Middle Eastern Adults Aged 30-55 Years of Age (CREATE)February 27th, 2023
- Cardiovascular Risk Categories and Attaining LDL-C Targets in Middle Eastern Adults Aged 30-55 Years of Age (CREATE)October 5th, 2023
- Cardiovascular Patients with No Standard Modifiable Risk Factors (SMuRF-Less-ME1)January 13th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: